Sara Sigler
Family · Groveport, OHNPI 1770968091
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 24.0% of the total. Reporting peaked in 2023 at $1,317 and has fallen 86.7% since, to $175 in 2025. Among family clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 223 payments — averaging $14.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$794
- Novo Nordisk$520
- Pfizer$190
- Lilly USA, LLC$178
- Bayer$169
- Merck$128
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,307100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $794 |
| Novo Nordisk | 35 | $520 |
| Pfizer | 11 | $190 |
| Lilly USA, LLC | 11 | $178 |
| Bayer | 8 | $169 |
| Merck | 8 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $126 |
| AstraZeneca | 8 | $110 |
| Teva Pharmaceuticals USA, Inc. | 5 | $110 |
| Abbott | 5 | $94 |
| GSK | 6 | $81 |
| Medtronic | 3 | $78 |
| Boehringer Ingelheim | 5 | $75 |
| Amgen | 4 | $72 |
| Exact Sciences | 3 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Astellas Pharma US Inc | 3 | $54 |
| Lucid Diagnostics Inc. | 3 | $51 |
| Vertex | 2 | $41 |
| Grifols USA, LLC | 2 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Johnson & Johnson | 2 | $24 |
| Viiv Healthcare Company | 1 | $23 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$3,307 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 76 | $898 |
| Omeprazole | 62 | $632 |
| Montelukast Sodium | 30 | $596 |
| Levothyroxine Sodium | 64 | $505 |
| Simvastatin | 31 | $429 |
| Losartan Potassium | 39 | $423 |
| Metformin Hcl ErMetformin Hcl | 20 | $421 |
| Gabapentin | 13 | $323 |
| Lisinopril | 53 | $295 |
| Potassium Chloride | 11 | $277 |
| Tamsulosin Hcl | 13 | $259 |
| Metoprolol Succinate | 23 | $257 |
| Ezetimibe | 13 | $242 |
| Amlodipine Besylate | 55 | $234 |
| Pravastatin Sodium | 14 | $207 |
Paid to pharmacies, not to this prescriber.
Other family in Groveport
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
- Kirt MunsonToledo$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.